Christopher Guiffre

Mr. Christopher D.
Guiffre is a President & Chief Operating Officer at Auron Therapeutics, Inc., a Chief Financial & Operating Officer at Pear Therapeutics (US), Inc. and a Member at Massachusetts Bar Association.
Mr. Guiffre was previously employed as a Chief Executive Officer by Daré Bioscience, Inc., a President, Chief Executive Officer & Director by Cerulean Pharma, Inc., a President & Chief Executive Officer by Mercator Therapeutics, Inc., a Secretary, Senior Vice President & General Counsel by Cubist Pharmaceuticals, Inc., a VP, General Counsel & Director-Legal Affairs by Renaissance Worldwide, Inc., a President & Chief Executive Officer by Alvos Therapeutics, Inc., an Associate by BMC Partners LLP, a Chief Business Officer by Hydra Biosciences, Inc., an Associate by Morgan, Lewis & Bockius LLP, and a Chief Executive Officer by Pear Therapeutics, Inc. He received his undergraduate degree from Babson College, a graduate degree from Boston College Law School and an MBA from Wallace E Carroll School of Management.